Skip to main content

FDA recall, , Moderate risk

LinkBio CORE Workstation

The LinkBio CORE Workstation may display an incorrect planning date on the start case menu screen.

What happened

Linkbio Corp. of Rockaway, New Jersey, recalled 5 units of the Linkbio CORE Workstation, a component of the CORE Shoulder System, because the workstation may display an incorrect "Planning Date" when viewing cases on the "Start Case" menu screen. The recall began on March 12, 2026, and was added to the FDA's Enforcement Report on April 10, 2026.

The product was distributed in Alabama, Florida, and Kansas. The FDA classified the recall on April 10, 2026, and included it in the weekly enforcement report on April 22, 2026.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:

  1. A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
  2. Talk to your health care provider before you stop using it.

Is yours affected?

Compare the details below with your product and check the FDA notice to confirm whether it is affected.

A UDI-DI is the device identifier printed with the barcode on the device label.

  1. LinkBio CORE Workstation, a component of the CORE Shoulder System.

    UDI-DI
    • 00810022403099
    Product code
    • 87-9136.
    Lot code
    All serial numbers of the CORE Workstation are affected.

Recall details

Company began the recall
Sold in

US Nationwide distribution in the state of Alabama, Florida, and Kansas.

Company
Linkbio Corp.Rockaway, New Jersey
Risk

Moderate risk

Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

Event ID
98594
Recall number
Z-1810-2026
Quantity recalled
5 units

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. In FDA's weekly enforcement report

  4. Listed on Recall Canary

  5. Summary updated

Summary by Recall Canary, written with AI · summary updated Oct 2, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)